CEACAM1 and inflammatory bowel disease: Furthermore, the researchers found that two patients with IBD have 284 exons with significantly different splicing rates at exons, including CEACAM1, an established IBD risk gene, suggesting that splicing analysis derived from RNA-seq experiments may play an important role in identifying pathogenesis of IBD (15).